Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Acquisition: NIB (ASX:NHF) share price on watch

The NIB Holdings Limited (ASX: NHF) share price is on watch today after announcing a digital health investment.

NIB’s acquisition

The private health insurer announced that it has bought a 50% stake in the Australian digital health start-up, Midnight Health, for a total of $4 million.

NIB said that this deal will help bring to life elements of NIB’s payer to partner (P2P) strategy as it moves towards being a business about good health and disease prevention as much as it has been about being there for members once they’re already sick, injured or in need of hospital support like giving birth.

The company also said that the partnership with Midnight Health is another step in delivering personalised health treatment packages in the broader healthcare market.

What is Midnight Health?

NIB explained that Midnight Health was established in October 2020 with a patient-led digital healthcare platform integrating telehealth technology, doctors, pharmacy networks and other health partners to provide a seamless patient experience.

The core areas of support are men’s health (Stagger) and women’s health (Youly), with plans to expand into senior health, gut health, cannabidiol products and other health needs in the coming months.

Management comments

NIB Managing Director Mark Fitzgibbon said:

There’s a large marketplace for healthcare products and services we’re generally not able to cover through private health insurance so this extends our reach. It also allows us to offer additional personalised support for private health insurance members.

Importantly, it will introduce many young people to NIB who may not yet be ready for private health insurance.

They already have more than 4,500 subscribers and we naturally expect this to grow with our close involvement.”

Is the NIB share price good value?

This deal isn’t material to NIB and said it wasn’t going to impact FY22 earnings.

However, if Midnight Health is successful then I can see that this digital service would add value for NIB and its shareholders.

I’m not sure if NIB shares are worth considering at the moment. It has gone through a recovery over the last 12 months, so I’m not sure if it’s good value today or how the private health insurance market is going to evolve.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content